Scientific paper - Original scientific paper
Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer
The Egyptian Heart Journal, 75 (2023), 11; 1-9. https://doi.org/10.1186/s43044-023-00331-y

Levicki, Rea; Lovrić Benčić, Martina; Ivanac Vranešić, Irena; Bradić, Lada; Begovac, Marta; Jug, Juraj; Dedić Plavetić, Natalija

Cite this document

Levicki, R., Lovrić Benčić, M., Ivanac Vranešić, I., Bradić, L., Begovac, M., Jug, J. & Dedić Plavetić, N. (2023). Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer. The Egyptian Heart Journal, 75. (11), 1-9. doi: 10.1186/s43044-023-00331-y

Levicki, Rea, et al. "Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer." The Egyptian Heart Journal, vol. 75, no. 11, 2023, pp. 1-9. https://doi.org/10.1186/s43044-023-00331-y

Levicki, Rea, Martina Lovrić Benčić, Irena Ivanac Vranešić, Lada Bradić, Marta Begovac, Juraj Jug and Natalija Dedić Plavetić. "Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer." The Egyptian Heart Journal 75, no. 11 (2023): 1-9. https://doi.org/10.1186/s43044-023-00331-y

Levicki, R., et al. (2023) 'Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer', The Egyptian Heart Journal, 75(11), pp. 1-9. doi: 10.1186/s43044-023-00331-y

Levicki R, Lovrić Benčić M, Ivanac Vranešić I, Bradić L, Begovac M, Jug J, and sur.. Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer. The Egyptian Heart Journal [Internet]. 2023 February 13 [cited 2024 September 17];75(11):1-9. doi: 10.1186/s43044-023-00331-y

R. Levicki, et al., "Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer", The Egyptian Heart Journal, vol. 75, no. 11, pp. 1-9, February 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:267:164278. [Accessed: 17 September 2024]

Please login to the repository to save this object to your list.